Pay in 4 interest-free payments of $6.97 Learn more
Ships within 48 hours · Estimated delivery Oct 8 - Oct 13
doi:10.1056/NEJMoa1607141 Lau J, Bloch P, Schffer L, et al
Each Ozempic pen contains semaglutide, a GLP-1 receptor agonist that works by stimulating insulin release, slowing gastric emptying, and reducing appetite
Semaglutide or tirzepatide may be appropriate if you: Have a body mass index (BMI) in the range qualifying for medical weight management Are committed to lifestyle changes (diet, physical activity, behavior) Do not have contraindications such as certain pancreatic or gallbladder disorders Have no allergies to the medications or excipients These drugs are not recommended in pregnancy, while breastfeeding, or in people with certain medical conditions unless cleared by a physician
Am J Hypertens (2004) 17:100510
It is important to help patients discuss their GLP-1 experience and get the support they need
US$ 28.75
US$ 21.24
US$ 26.77
US$ 26.51
US$ 24.61
US$ 29.17
